Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03210831 · ClinicalTrials.gov registry record
Early Predictors of Necrotizing Enterocolitis in Neonates
A clinical trial of Necrotizing Enterocolitis, sponsored by Nationwide Children's Hospital.
- Recruiting
- Registry status
- 450
- Enrollment target
- 1
- Study location
NCT03210831: Recruiting study of Necrotizing Enterocolitis, sponsored by Nationwide Children's Hospital.
NCT03210831 is a study of Necrotizing Enterocolitis that is actively recruiting participants, run by Nationwide Children's Hospital. The registered enrollment target is 450 participants, above the 281-participant average among 14 other Necrotizing Enterocolitis trials with a reported enrollment target (60% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03210831, a study of Necrotizing Enterocolitis, is actively recruiting participants, sponsored by Nationwide Children's Hospital.
- RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to identify neonates who are predisposed to Necrotizing Enterocolitis (NEC). the investigators will determine the effectiveness of non-invasive measures as well as biochemical markers to identify neonates early in the disease process. Thus, the investigators aim to identify infants with NEC prior to the onset of symptoms to institute or test treatments in the long term to prevent the progression of the disease in these infants.
Primary Outcome
splanchnic tissue oxygenation as a predictor of NEC
Conditions Studied
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2017-09-06 |
| Est. Completion | 2026-12 |
What NCT03210831 shows while recruiting
NCT03210831 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, above the 281-participant average among 14 other Necrotizing Enterocolitis trials with a reported enrollment target (60% higher).
The record links to 1 condition, with Necrotizing Enterocolitis appearing as the primary indexed condition, and to 0 interventions.
NCT03210831 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03210831 about?
NCT03210831 is a clinical study titled "Early Predictors of Necrotizing Enterocolitis in Neonates". The goal of this project is to identify neonates who are predisposed to Necrotizing Enterocolitis (NEC). the investigators will determine the effectiveness of non-invasive measures as well as biochemical markers to identify neonates early in the disease process. Thus, the investigators aim to identi...
What is the current status of trial NCT03210831?
This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2017-09-06. Estimated completion is 2026-12.
What conditions does trial NCT03210831 study?
This clinical trial studies the following conditions: Necrotizing Enterocolitis.
Who is sponsoring clinical trial NCT03210831?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03210831 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Necrotizing Enterocolitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03210831's enrollment target sits among peer trials
450 2nd of 14 the highest of 14 other Necrotizing Enterocolitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Necrotizing Enterocolitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis
RECRUITING · Phase 1
-
Early Routine vs. Selective Human Milk Fortification in Extremely Preterm Infants
RECRUITING · NA
-
A Cohort Study of the Intestinal Microbiota of Premature Infants
ACTIVE NOT RECRUITING
-
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study
ACTIVE NOT RECRUITING · Phase 3
-
RBC Irradiation, Anemia and Gut Injury
ACTIVE NOT RECRUITING
-
RIC-NEC Randomized Controlled Trial
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI